ASIA-PACIFIC
CHINA
CHINA TOWER AIMS BIG
-OBILEûPHONEûINFRASTRUCTUREûCOMPANYûCHINA
TOWERûISûPLANNINGûTOûRAISEûUPûTOû53BNû
FROMûAû(ONGû+ONGû)0/ûATûAûVALUATIONûOFûUPûTOû
53BNûACCORDINGûTOûPEOPLEûCLOSEûTOûTHEûDEAL
4HEûCOMPANYûISûTALKINGûTOûPOTENTIALû
CORNERSTONEûINVESTORSûAHEADûOFûTHEûLISTINGû
ANDûISûPLANNINGûTOûSELLûABOUTûûOFûITSû
ENLARGEDûSHAREûCAPITALûTHEûPEOPLEûSAIDû4HEû
53BNûVALUATIONûWOULDûBEûTHEûTOPûENDûOFû
ANûINDICATIVEûPRICEûRANGE
#HINAû4OWERûISûSETûTOûOPENûBOOKSûONû*ULYû
ûANDûPRICEûTHEûDEALûONû!UGUSTûûTHEû
PEOPLEûSAID
!Tû53BNû#HINAû4OWERSû)0/ûWILLû
SURPASSûTHEû(+BNû53BN ûLISTINGûOFû
8IAOMIûEARLIERûTHISûMONTHûBECOMINGûTHEû
largest IPO globally since Chinese e-commerce
GIANTû!LIBABASû53BNû53ûLISTINGûINû
!DDINGûAûSTANDARDûGREENSHOEûOPTIONûOFû
ûCOULDûBRINGûTHEûPROCEEDSûTOûABOUTû
53BNûINûLINEûWITHûEARLIERûEXPECTATIONS
#HINAû-OBILEû#HINAû5NICOMûANDû#HINAû
4ELECOMûSETûUPû#HINAû4OWERûINû*ULYûûTOû
BEûRESPONSIBLEûFORûTHEûCONSTRUCTIONû
MAINTENANCEûANDûOPERATIONSûOFûTHEIRû
telecoms towers and infrastructure across
THEûCOUNTRY
#HINAû-OBILEûHOLDSûAûûSTAKEûINû#HINAû
4OWERû#HINAû5NICOMûHASûûANDû#HINAû
4ELECOMûû3TATEûASSETûMANAGEMENTû
lRMû#HINA2EFORMû(OLDINGûHASûAûûSTAKE
CICC and Goldman Sachs AREûTHEûJOINTû
SPONSORSûFORûTHEû#HINAû4OWERûmOTATION
BOOKS COVERED FOR PINDUODUO’S IPO
4HEûBOOKSûOFû#HINESEûONLINEûGROUPû
discounter PINDUODUOSû.ASDAQû)0/ûOFûUPûTOû
53BNûWEREûCOVEREDûONû7EDNESDAYû
ACCORDINGûTOûPEOPLEûCLOSEûTOûTHEûDEAL
4HEû)0/ûOFûMû!MERICANûDEPOSITARYû
SHARESûORûABOUTûûOFûTHEûENLARGEDûSHAREû
CAPITALûWOULDûBEûONEûOFûTHEûLARGESTû#HINESEû
LISTINGSûINûTHEû53ûTHISûYEAR
)TûISûBEINGûMARKETEDûATûANûINDICATIVEûPRICEû
RANGEûOFû53
4HEûPRICEûRANGEûVALUESûTHEûCOMPANYûATû
ABOUTû53BNnBNû4HEûRANGEûALSOû
REPRESENTSûAûûPRICE
TO
SALESûRATIOûOFûn
ûANDûAûûNON
'!!0û0%ûOFûn
%XISTINGûSHAREHOLDERSû4ENCENTû(OLDINGSû
ANDû3EQUOIAû#APITALûHAVEûEACHûSHOWNû
INTERESTûINûBUYINGûUPûTOû53MûINûTHEû)0/
4HEûDEALûWILLûPRICEûONû*ULYû
CICC, Credit Suisse, China Renaissance and
Goldman SachsûAREûTHEûBOOKRUNNERS
GANFENG TO LAUNCH IPO POST-SUMMER
3HENZHEN
LISTEDûGANFENG LITHIUMûISûPLANNINGû
TOûLAUNCHûITSû(ONGû+ONGû)0/ûOFûUPûTOû53BNû
AFTERûTHEûSUMMERûWHENûITûHOPESûLITHIUMû
PRICESûWILLûBEûMOREûSTABLEûPEOPLEûCLOSEûTOû
THEûDEALûSAID
4HEûSILVER
WHITEûMETALûWASûSEENûTRADINGûATû
AûRECORDûHIGHûOFûûPOINTSûINû*ANUARYû)TSû
PRICEûHASûSINCEûPLUMMETEDûBYûûTOûû
POINTSûONûû*ULYûACCORDINGûTOûDATAûWEBSITEû
4RADINGû%CONOMICS
'ANFENGSû!
SHAREûPRICEûHASûFALLENûABOUTû
ûSINCEûTHEûBEGINNINGûOFûTHEûYEARû
FOLLOWINGûTHEûDROPûINûLITHIUMûPRICES
4HEûCOMPANYûCOMPLETEDûPRE
MARKETINGû
FORûITSû)0/ûEARLIERûTHISûMONTH
)TûISûTENTATIVELYûLOOKINGûTOûSELLûûOFû
ITSûENLARGEDûSHAREûCAPITALûPRE
GREENSHOEû
ANDûûPOST
GREENSHOEûACCORDINGûTOûAû
TERMûSHEETûSEENûBYû)&2
4HEûINITIALûSPLITûFORûTHEûINSTITUTIONALû
tranche and the Hong Kong retail offering is
ûANDû
4HEûPROCEEDSûWILLûBEûUSEDûFORûUPSTREAMû
MERGERSûANDûACQUISITIONSûOUTPUTûEXPANSIONû
ANDûRESEARCHûANDûDEVELOPMENTûAMONGû
OTHERûTHINGS
ASIA-PACIFIC EQUITIES
BOOKRUNNERS: 1/1/2018 TO DATE
Managing No of Total Share
bank or group issues US$(m) (%)
1 Morgan Stanley 52 11,625.42 8.5
2 Citigroup 52 9,162.75 6.7
3 Goldman Sachs 47 8,692.26 6.4
4 UBS 37 7,222.91 5.3
5 BAML 14 6,460.21 4.7
6 CICC 16 6,244.64 4.6
7 Citic 31 4,708.16 3.5
8 Credit Suisse 28 4,661.26 3.4
9 JP Morgan 27 4,215.98 3.1
10 Sumitomo Mitsui Finl 42 3,120.80 2.3
Total 1,403 136,024.63
Including all domestic and international deals and rights issues
Source: Thomson Reuters SDC code: C4a1
ASIA-PACIFIC EQUITIES (EX-JAPAN)
BOOKRUNNERS: 1/1/2018 TO DATE
Managing No of Total Share
bank or group issues US$(m) (%)
1 Morgan Stanley 35 9,658.65 8.0
2 Citigroup 48 8,756.77 7.3
3 Goldman Sachs 46 8,639.68 7.2
4 UBS 35 6,982.21 5.8
5 CICC 16 6,244.64 5.2
6 BAML 11 5,866.06 4.9
7 Citic 31 4,708.16 3.9
8 Credit Suisse 27 4,488.13 3.7
9 JP Morgan 23 3,446.05 2.9
10 China Securities 21 2,964.14 2.5
Total 1,274 120,710.83
Including all domestic and international deals and rights issues
Source: Thomson Reuters SDC code: C4a2
WEEK IN NUMBERS
5.4%
RUBIUS THERAPEUTICS OPENED UP 33%
ABOVE ITS IPO PRICE ON WEDNESDAY’S
DEBUT. THE COMPANY HAD COMPLETED
THE LARGEST BIOTECH IPO OF THE
YEAR, RAISING US$241m AFTER PRICING
US$1 ABOVE THE TOP OF MARKETING
GUIDANCE. SHARES ENDED WEDNESDAY
ON NASDAQ UP JUST 5.4%
34%
MORGAN STANLEY’S Q2 RESULTS SHOWED
EQUITY UNDERWRITING REVENUES UP 34%
OVER THE SECOND QUARTER OF 2017 TO
US$541m. ITS EARNINGS FELL BETWEEN
JP MORGAN AT US$570m AND GOLDMAN
SACHS’ US$489m, WITH ALL THREE BANKS
PUTTING IN A STRONG PERFORMANCE
HK$42.6bn
THE FULL GREENSHOE WAS EXERCISED
ON XIAOMI’S HONG KONG FLOAT, TAKING
THE CHINESE SMARTPHONE MAKER’S IPO
TO HK$42.6bn (US$5.4bn). SHARES AT THE
TIME WERE TRADING AROUND 30% UP
FROM THE IPO
US$1.56bn
TILRAY BECAME THE FIRST CANNABIS
GROWER TO GO PUBLIC ON A US EXCHANGE
WITH A MARKET CAPITALISATION OF
US$1.56bn, HAVING LAST YEAR GENERATED
REVENUE OF US$20.5m. PRICING CAME AT
US$17 PER SHARE, ABOVE THE US$14-$16
PRICE RANGE
50% + one share
THE SLOVENIAN GOVERNMENT HAS
REVIVED THE PRIVATISATION OF NOVA
LJUBLJANSKA BANKA AND WILL SELL A
MAJORITY OF THE BANK THROUGH AN IPO
BEFORE YEAR-END, WITH ITS REMAINING
25% STAKE TO BE SOLD IN 2019
15
17
19
21
23
25
27
29
31
33
35
Marketing range
IPO price
Rubius Therapeutics
09.44 10.44 11.44 12.44 13.44 14.44
US$